
Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial
Author(s) -
James Liu,
Denise Black,
Lisa Larkin,
Shelli Graham,
Brian Bernick,
Sebastián Mirkin
Publication year - 2020
Publication title -
menopause
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.086
H-Index - 103
eISSN - 1530-0374
pISSN - 1072-3714
DOI - 10.1097/gme.0000000000001631
Subject(s) - medicine , placebo , breast cancer , incidence (geometry) , hormone replacement therapy (female to male) , gynecology , adverse effect , mammography , hormone therapy , vasomotor , randomized controlled trial , cancer , optics , testosterone (patch) , physics , alternative medicine , pathology
To evaluate the effect of a single-capsule, bioidentical 17β-estradiol (E2) and progesterone (P4) hormone therapy on mammograms and breasts in postmenopausal women after 1 year of use.